ADIPOQ and chronic kidney disease: However, contrary to findings in cellular and animal models, high levels of adiponectin have been shown to independently predict both all-cause and cardiovascular mortality in many different clinical settings, including patients with coronary artery disease, chronic kidney disease, and LEAD [28, 29].